These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32626833)

  • 1. Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome.
    Kamath BM; Spino C; McLain R; Magee JC; Fredericks EM; Setchell KD; Miethke A; Molleston JP; Mack CL; Squires RH; Alonso EM; Murray KF; Loomes KM; Kyle Jensen M; Karpen SJ; Rosenthal P; Thomas D; Sokol RJ; Shneider BL;
    Hepatol Commun; 2020 Jul; 4(7):1012-1018. PubMed ID: 32626833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Novel Tool to Assess the Impact of Itching in Pediatric Cholestasis.
    Kamath BM; Abetz-Webb L; Kennedy C; Hepburn B; Gauthier M; Johnson N; Medendorp S; Dorenbaum A; Todorova L; Shneider BL
    Patient; 2018 Feb; 11(1):69-82. PubMed ID: 28710680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome.
    Shneider BL; Spino CA; Kamath BM; Magee JC; Ignacio RV; Huang S; Horslen SP; Molleston JP; Miethke AG; Kohli R; Leung DH; Jensen MK; Loomes KM; Karpen SJ; Mack C; Rosenthal P; Squires RH; Baker A; Rajwal S; Kelly D; Sokol RJ; Thompson RJ;
    Hepatol Commun; 2022 Aug; 6(8):1922-1933. PubMed ID: 35672955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome.
    Shneider BL; Spino C; Kamath BM; Magee JC; Bass LM; Setchell KD; Miethke A; Molleston JP; Mack CL; Squires RH; Murray KF; Loomes KM; Rosenthal P; Karpen SJ; Leung DH; Guthery SL; Thomas D; Sherker AH; Sokol RJ;
    Hepatol Commun; 2018 Oct; 2(10):1184-1198. PubMed ID: 30288474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of Pruritus in a Child With Alagille Syndrome Treated With Maralixibat for Seven Years: Durable Response and Discontinuation of Other Medications.
    Garcia A; Hsu E; Lin HC
    JPGN Rep; 2023 Aug; 4(3):e335. PubMed ID: 37600618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maralixibat Treatment Response in Alagille Syndrome is Associated with Improved Health-Related Quality of Life.
    Kamath BM; Goldstein A; Howard R; Garner W; Vig P; Marden JR; Billmyer E; Anderson A; Kirson N; Jacquemin E; Gonzales E
    J Pediatr; 2023 Jan; 252():68-75.e5. PubMed ID: 36096175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ileal Bile Acid Transporter Blockers for Cholestatic Liver Disease in Pediatric Patients with Alagille Syndrome: A Systematic Review and Meta-Analysis.
    Muntaha HST; Munir M; Sajid SH; Sarfraz Z; Sarfraz A; Robles-Velasco K; Sarfraz M; Felix M; Cherrez-Ojeda I
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Bile Acid Profiling and Mixed Model Analysis Reveal Biomarkers Associated with Pruritus Reduction in Maralixibat-Treated Patients with BSEP Deficiency.
    Zhao X; Zhang W; Vig P; Kostrub C; Setchell KDR
    Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor.
    Sokol RJ; Gonzales EM; Kamath BM; Baker A; Vig P; Mogul DB; Garner W; Hansen BE; Jacquemin E; Thompson RJ
    Hepatology; 2023 Dec; 78(6):1698-1710. PubMed ID: 37278241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world experience of maralixibat in Alagille syndrome: Novel findings outside of clinical trials.
    Himes R; Rosenthal P; Dilwali N; Smith K; Venick R; Gonzalez-Peralta RP
    J Pediatr Gastroenterol Nutr; 2024 Mar; 78(3):506-513. PubMed ID: 38334237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
    Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis.
    Mayo MJ; Pockros PJ; Jones D; Bowlus CL; Levy C; Patanwala I; Bacon B; Luketic V; Vuppalanchi R; Medendorp S; Dorenbaum A; Kennedy C; Novak P; Gu J; Apostol G; Hirschfield GM
    Hepatol Commun; 2019 Mar; 3(3):365-381. PubMed ID: 30859149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of funded multicenter prospective longitudinal databases to inform clinical trials in rare diseases-Examination of cholestatic liver disease in Alagille syndrome.
    Shneider BL; Kamath BM; Magee JC; Goodrich NP; Loomes KM; Ye W; Spino C; Alonso EM; Molleston JP; Bezerra JA; Wang KS; Karpen SJ; Horslen SP; Guthery SL; Rosenthal P; Squires RH; Sokol RJ;
    Hepatol Commun; 2022 Aug; 6(8):1910-1921. PubMed ID: 35506349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study.
    Mrowietz U; Chouela EN; Mallbris L; Stefanidis D; Marino V; Pedersen R; Boggs RL
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1114-20. PubMed ID: 25376448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.
    Hansen BE; Vandriel SM; Vig P; Garner W; Mogul DB; Loomes KM; Piccoli DA; Rand EB; Jankowska I; Czubkowski P; Gliwicz-Miedzińska D; Gonzales EM; Jacquemin E; Bouligand J; D'Antiga L; Nicastro E; Arnell H; Fischler B; Sokal É; Demaret T; Siew S; Stormon M; Karpen SJ; Romero R; Ebel NH; Feinstein JA; Roberts AJ; Evans HM; Sundaram SS; Chaidez A; Hardikar W; Shankar S; Fischer RT; Lacaille F; Debray D; Lin HC; Jensen MK; Jaramillo C; Karthikeyan P; Indolfi G; Verkade HJ; Larson-Nath C; Quiros-Tejeira RE; Valentino PL; Rogalidou M; Dezsőfi A; Squires JE; Schwarz K; Calvo PL; Bernabeu JQ; Zizzo AN; Nebbia G; Bulut P; Santos-Silva E; Fawaz R; Nastasio S; Karnsakul W; Tamara ML; Busoms CM; Kelly DA; Sandahl TD; Jimenez-Rivera C; Banales JM; Mujawar Q; Li LT; She H; Wang JS; Kim KM; Oh SH; Sanchez MC; Cavalieri ML; Lee WS; Hajinicolaou C; Lertudomphonwanit C; Waisbourd-Zinman O; Arikan C; Alam S; Carvalho E; Melere M; Eshun J; Önal Z; Desai DM; Wiecek S; Pinto RB; Wolters VM; Garcia J; Beretta M; Kerkar N; Brecelj J; Rock N; Lurz E; Blondet N; Shah U; Thompson RJ; Kamath BM;
    Hepatology; 2024 Jun; 79(6):1279-1292. PubMed ID: 38146932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review: The Epidemiology, Natural History, and Burden of Alagille Syndrome.
    Kamath BM; Baker A; Houwen R; Todorova L; Kerkar N
    J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):148-156. PubMed ID: 29543694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the pruritus on the quality of life: a preliminary study.
    Erturk IE; Arican O; Omurlu IK; Sut N
    Ann Dermatol; 2012 Nov; 24(4):406-12. PubMed ID: 23197905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module.
    Varni JW; Burwinkle TM; Katz ER; Meeske K; Dickinson P
    Cancer; 2002 Apr; 94(7):2090-106. PubMed ID: 11932914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life and Its Determinants in a Multicenter Cohort of Children with Alagille Syndrome.
    Kamath BM; Chen Z; Romero R; Fredericks EM; Alonso EM; Arnon R; Heubi J; Hertel PM; Karpen SJ; Loomes KM; Murray KF; Rosenthal P; Schwarz KB; Subbarao G; Teckman JH; Turmelle YP; Wang KS; Sherker AH; Sokol RJ; Magee JC;
    J Pediatr; 2015 Aug; 167(2):390-6.e3. PubMed ID: 26059338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Initial Psychometric Properties of Two Itch-Related Measures: Scratch Intensity and Impact, Sleep-Related Itch and Scratch.
    Heckman CJ; Riley M; Valdes-Rodriguez R; Yosipovitch G
    J Invest Dermatol; 2020 Nov; 140(11):2138-2145.e1. PubMed ID: 32298670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.